Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Human-level artificial intelligence (AI), popularly referred to as Artificial General Intelligence (AGI) could arrive by as ...
DeepMind has released a lengthy paper outlining its approach to AI safety as it tries to build advanced systems that could ...
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Google’s DeepMind is reportedly holding back from publishing AI research papers over fears of losing its competitive edge.
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Demis Hassabis was a child chess prodigy, achieving master status in his teens. In a lecture at the University of Cambridge, the Google Deepmind CEO said chess led him to his first experience with AI.
In AI, games are more than just fun—they can reconceive what’s possible. Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, knows this firsthand. In 2016, after AlphaGo—the AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results